FindTrial
Sign In

A clinical study to compare the effect of Tiladi Kwath and Rajapravartini Vati in women suffering from Artavakshaya (oligo-hypomenorrhea)

An Open Label Randomized Comparative Clinical Study of Tiladi Kwath and Rajapravartini Vati in the Management of Artavakshaya with Special Reference to Oligo-Hypomenorrhea - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110235
Enrollment
60
Registered
2026-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

Seth RV Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: 13 to 40 yrs Interval between two menstrual cycles more than 35 days. Duration of flow less than 3 days Hb: more than 8 gm/dl Patient from all socio-economic class

Exclusion criteria

Exclusion criteria: Patients below 13 and above 40 yrs. Patients having primary amenorrhea. Patients within 2 yr of menarche Pregnant women Lactating women Major systemic diseases likely to influence menstrual cycle like Diabetes Mellites, Thyroid Disfunction Known patients of malignancy, Tuberculosis

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms of Artavakshaya (Oligo-Hypomenorrhea), assessed by: Interval between menstrual cycles (Yathochitkaladarshan) Duration of menstrual flow (Alpata) Quantity of menstrual bleeding (pads/day) Pain during menstruation (Yonivedana)Timepoint: Baseline and at the end of each menstrual cycle (approximately Day 30, Day 60, and Day 90)—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Archana Mahajan

APMs Ayurved Mahavidyalaya Sion

bansodepooja9999@gmail.com9766806714

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026